Maxim Group analyst Jason Kobert reiterated his Buy rating and $7 price target on Galena Biopharma (NASDAQ: GALE), saying as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE